DESIGN AND METHODS : We compared the clinical and hematologic responses to change in % V617F ( molecular response ) in 73 patients with polycythemia vera treated with either interferon ( rIFNa-2b : 28 , Peg-rIFNa-2a : 18 ) or non-interferon drugs ( n = 27 ) , which included hydroxyurea ( n = 8 ) , imatinib ( n = 12 ) , dasatinib ( n = 5 ) , busulfan ( n = 1 ) , and radioactive phosphorus ( n = 1 ) .